(Q30988044)

English

Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

0 references

Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Alzheimer's disease

0 references

0 references

author name string

Gauthier S

1

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Wirth Y

2

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Möbius HJ

3

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

language of work or name

0 references

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

International Journal of Geriatric Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

459-464

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Behavioral problems in dementia: a factor analysis of the neuropsychiatric inventory.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1341

21 January 2018

Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1341

21 January 2018

Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1341

21 January 2018

Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan).

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1341

21 January 2018

Pharmacologic Management of Agitation in Alzheimer’s Disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1341

21 January 2018

Memantine in moderate-to-severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1341

21 January 2018

Agitation in Alzheimer’s Disease Is a Manifestation of Frontal Lobe Dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1341

21 January 2018

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1341

21 January 2018

Cholinesterase Inhibitor Therapies and Neuropsychiatric Manifestations of Alzheimer’s Disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1341

21 January 2018

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1341

7 January 2021

based on heuristic

inferred from DOI database lookup

The Neuropsychiatric Inventory: assessing psychopathology in dementia patients

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1341

7 January 2021

based on heuristic

inferred from DOI database lookup

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1341

7 January 2021

based on heuristic

inferred from DOI database lookup

Institutionalization of Alzheimer's disease patients: reducing precipitating factors through family counseling.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1341

7 January 2021

based on heuristic

inferred from DOI database lookup

Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1341

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/GPS.1341

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30988044&oldid=1546268877"